Stay updated on Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry v3.3.2, replacing the previous v3.2.0 entry.
    Difference
    0.1%
    Check dated 2025-11-25T10:41:12.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A government funding notice appears, warning that information may not be up to date and that transactions may not be processed, with links to cc.nih.gov and opm.gov for status updates.
    Difference
    0.8%
    Check dated 2025-11-18T06:54:07.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The history shows multiple versions with updates to study status and recruitment across several dates, including a later entry in 2025. This indicates ongoing updates to the trial record.
    Difference
    0.1%
    Check dated 2025-11-03T20:55:46.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    13%
    Check dated 2025-10-06T05:21:23.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-29T03:01:58.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    A new page revision (v3.0.2) with updated date-based status lines was added, replacing v3.0.1 and removing a 'Back to Top' link; this indicates a standard update to revision metadata and study status rather than meaningful content changes.
    Difference
    2%
    Check dated 2025-09-14T19:00:07.000Z thumbnail image

Stay in the know with updates to Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.